Puerarin downregulates KEAP1, promotes NRF2 expression and nuclear transfer, and can prevent and ameliorate myocardial fibrosis. Its therapeutic effect may be related to the upregulation of UGT1A1 in NRCF by NRF2. Here, NFE2L2 is linked to Myocardial fibrosis.